159 related articles for article (PubMed ID: 1569603)
1. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.
Xing PX; Prenzoska J; Layton GT; Devine PL; McKenzie IF
J Natl Cancer Inst; 1992 May; 84(9):699-703. PubMed ID: 1569603
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies reacting with the MUC2 mucin core protein.
Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
[TBL] [Abstract][Full Text] [Related]
3. Anti-peptide monoclonal antibodies to intestinal mucin 3.
Apostolopoulos V; Xing PX; McKenzie IF
J Gastroenterol Hepatol; 1995; 10(5):555-61. PubMed ID: 8963031
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
5. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
7. Second generation anti-MUC1 peptide monoclonal antibodies.
Xing PX; Prenzoska J; Quelch K; McKenzie IF
Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
[TBL] [Abstract][Full Text] [Related]
8. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
Durrant LG; Jacobs E; Price MR
Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.
Reis CA; Sørensen T; Mandel U; David L; Mirgorodskaya E; Roepstorff P; Kihlberg J; Hansen JE; Clausen H
Glycoconj J; 1998 Jan; 15(1):51-62. PubMed ID: 9530956
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human colon and colorectal carcinoma.
Thompson CH; Jones SL; Pihl E; McKenzie IF
Br J Cancer; 1983 May; 47(5):595-605. PubMed ID: 6342646
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy.
Siddiki B; Ho JJ; Huang J; Byrd JC; Lau E; Yuan M; Kim YS
Int J Cancer; 1993 May; 54(3):467-74. PubMed ID: 7685327
[TBL] [Abstract][Full Text] [Related]
12. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody.
Gambús G; de Bolós C; Andreu D; Francí C; Egea G; Real FX
Gastroenterology; 1993 Jan; 104(1):93-102. PubMed ID: 7678241
[TBL] [Abstract][Full Text] [Related]
13. Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes.
Teh JG; Xing PX; McKenzie IF
Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():207-16. PubMed ID: 1699885
[TBL] [Abstract][Full Text] [Related]
14. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
15. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
Zhang S; Zhang HS; Cordon-Cardo C; Ragupathi G; Livingston PO
Clin Cancer Res; 1998 Nov; 4(11):2669-76. PubMed ID: 9829729
[TBL] [Abstract][Full Text] [Related]
16. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
17. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
18. Heteroclitic recognition of combinatorial TX1TX2T peptide mixtures by mucin-2 protein specific monoclonal antibody.
Windberg E; Uray K; Illyés E; Skribanek Z; Price MR; Sebestyén F; Hudecz F
J Pept Sci; 2004 Jan; 10(1):56-65. PubMed ID: 14959892
[TBL] [Abstract][Full Text] [Related]
19. Separation of distinct MUC2 mucin glycoforms using two anti-peptide monoclonal antibodies.
Price MR; Ladányi A; Uray K; Ma Y; Sekowski M; Durrant LG
Int J Oncol; 1999 Oct; 15(4):803-9. PubMed ID: 10493965
[TBL] [Abstract][Full Text] [Related]
20. Expression of a high molecular weight mucin-type glycoprotein in human colon cancer as defined by monoclonal antibody 1D3.
Gangopadhyay A; Barlow JJ; Petrelli NJ; Tsukada Y; Bhattacharya-Chatterjee M
Hybridoma; 1988 Apr; 7(2):141-54. PubMed ID: 3286482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
